PT IFARS PHARMACEUTICAL LABORATORI
Company Profile:
Business Nature: Manufacturer
Company Overview:
PT IFARS PHARMACEUTICAL LABORATORIES is a prominent pharmaceutical manufacturing company based in Indonesia. Established in 1974, the company specializes in the development, production, and distribution of a wide range of high-quality pharmaceutical products. Their portfolio includes various therapeutic categories such as analgesics, antibiotics, anti-inflammatory drugs, and vitamins, offered in multiple dosage forms including tablets, capsules, syrups, and suspensions.
The company operates a state-of-the-art manufacturing facility that strictly adheres to Good Manufacturing Practices (GMP) as mandated by the Indonesian National Agency of Drug and Food Control (BPOM). With a strong commitment to healthcare innovation and quality assurance, PT IFARS focuses on providing affordable and effective medication to meet the growing healthcare demands of the Indonesian market and beyond. They maintain a robust distribution network to ensure their products are accessible to hospitals, clinics, and pharmacies nationwide.
Enterprise Products
PT IFARS PHARMACEUTICAL LABORATORI Product List
Analgesics and Antipyretics
Antalgin
Paracetamol
Asam Mefenamat
Ibuprofen
Antibiotics and Anti-infectives
Amoxicillin
Ampicillin
Ciprofloxacin
Chloramphenicol
Cefadroxil
Cotrimoxazole
Erythromycin
Metronidazole
Thiamphenicol
Gastrointestinal Agents
Antasida Doen
Famotidine
Omeprazole
Domperidone
Cardiovascular and Metabolic Agents
Amlodipine
Captopril
Simvastatin
Metformin
Glibenclamide
Respiratory Agents
Ambroxol
Bromhexine
Dexamethasone
Prednisone
CTM (Chlorpheniramine Maleate)
Vitamins and Supplements
Vitamin B Complex
Vitamin C
Vitamin B1
Vitamin B6
Others
Betahistine Mesylate
Acyclovir
Business Registration Information:
Manager:
Phone:
E-mail:
Official Website:
Address:
Jl. Solo-Sragen KM 14, Pulosari, Kebakkramat, Karanganyar, Central Java, 57762, Indonesia
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.